CB 1954 revisited. II. Toxicity and antitumour activity (Q42226399)

19 October 2017

title

CB 1954 revisited. II. Toxicity and antitumour activity (English)

1 reference

19 October 2017

P Workman

1 reference

19 October 2017

J E Morgan

1 reference

19 October 2017

K Talbot

1 reference

19 October 2017

K A Wright

1 reference

19 October 2017

J Donaldson

1 reference

19 October 2017

P R Twentyman

1 reference

19 October 2017

publication date

1 January 1986

1 reference

Cancer Chemotherapy and Pharmacology

19 October 2017

published in

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

page(s)

9-14

1 reference

Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00255279

Interactions between misonidazole and hyperthermia in EMT6 spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00255279

Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00255279

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00255279

Medicinal nitro-compounds. Part II. Search for ortho-interactions in tumour-inhibitory 2,4-dinitrophenylaziridines

21 January 2018

1 reference

12 December 2020

Radiosensitizing and Cytotoxicity Studies with CB 1954 (2,4-Dinitro-5-Aziridinylbenzamide)

1 reference

12 December 2020

The metabolism of the anti-tumour agent 5-(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954)

1 reference

12 December 2020

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors—I. Adriamycin

1 reference

12 December 2020

Selective inhibition of ribonucleotide reductase by the monofunctional alkylating agent 5(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954)

1 reference

12 December 2020

The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments

1 reference

12 December 2020

Tumour-growth inhibitory nitrophenylaziridines and related compounds: Structure-activity relationships. II

1 reference

12 December 2020

In vitro analysis of the response of multicellular tumor spheroids exposed to chemotherapeutic agents in vitro or in vivo

1 reference

12 December 2020

2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.

1 reference

12 December 2020

CB 1954 revisited. I. Disposition kinetics and metabolism

1 reference

12 December 2020

Tumour-growth inhibitorynitrofphenylaziridines and related compounds structure-activity relationships

1 reference

12 December 2020

Cell survival recovery kinetics in the KHT sarcoma following treatment with five alkylating agents and misonidazole

1 reference

12 December 2020

Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells

1 reference

12 December 2020

Metabolic activation of nitrofurantoin—possible implications for carcinogenesis

1 reference

12 December 2020

Changes in sensitivity to radiation and to bleomycin occurring during the life history of monolayer cultures of a mouse tumour cell line

1 reference

12 December 2020

Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the walker tumour

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00255279

1 reference

Dimensions Publication ID

19 October 2017

1039497702

0 references

1 reference